de la Torre Hernandez José M, Rumoroso José R, Subinas Asier, Gonzalo Nieves, Ojeda Soledad, Pan Manuel, Martín Yuste Victoria, Suárez Alfonso, Hernández Felipe, Teruel Luis, Moreu José, Cubero José M, Cascón José D, Vinhas Hugo, Lozano Íñigo, Martin Moreiras Javier, Pérez de Prado Armando, Goicolea Javier, Escaned Javier
Hospital U. Marques de Valdecilla, Santander, Spain.
EuroIntervention. 2017 Jun 2;13(2):e219-e226. doi: 10.4244/EIJ-D-16-00764.
Limited data exist on the treatment and outcomes of patients with chronic total occlusions due to in-stent restenosis (CTO-ISR). We sought to evaluate results and clinical outcomes in percutaneous interventions over CTO-ISR.
We conducted a registry in 16 centres involving consecutive patients undergoing attempted percutaneous intervention over CTO-ISR. A total of 233 patients were included, 192 (82.4%) with a successful acute result. The success rate was significantly lower in patients with: lesion in the circumflex artery, ostial lesions, J score >3 and no femoral access. The presence of tandem lesions (OR 0.19, 95% CI: 0.06-0.68; p=0.01) was identified as an independent predictor for outcome. After a median follow-up of 20 months, cardiac death in the successful vs. failed groups was 3% and 8.3%, respectively (p=0.09). Independent predictors for mortality were previous CABG (HR 8, 95% CI: 1.3-50; p=0.02) and multivessel disease (HR 2.3, 95% CI: 1.2-4.3; p=0.01). In the successful group, TLR was 15%, re-occlusion 6% and definite/probable stent thrombosis 1.8%.
Percutaneous treatment of CTO due to ISR in contemporary practice shows a high success rate, resulting in good long-term results. The angiographic and procedural predictors identified may contribute to improving procedural outcome through better patient selection.
关于支架内再狭窄所致慢性完全闭塞(CTO-ISR)患者的治疗及预后的数据有限。我们旨在评估经皮介入治疗CTO-ISR的结果及临床预后。
我们在16个中心进行了一项登记研究,纳入连续接受CTO-ISR经皮介入治疗尝试的患者。共纳入233例患者,192例(82.4%)急性结果成功。在以下患者中成功率显著较低:回旋支动脉病变、开口病变、J评分>3以及无股动脉入路。串联病变的存在(比值比0.19,95%置信区间:0.06-0.68;p=0.01)被确定为预后的独立预测因素。中位随访20个月后,成功组与失败组的心脏死亡率分别为3%和8.3%(p=0.09)。死亡率的独立预测因素为既往冠状动脉旁路移植术(HR 8,95%置信区间:1.3-50;p=0.02)和多支血管病变(HR 2.3,95%置信区间:1.2-4.3;p=0.01)。在成功组中,靶病变血运重建率为15%,再闭塞率为6%,明确/可能的支架血栓形成率为1.8%。
在当代实践中,经皮治疗ISR所致CTO成功率高,长期结果良好。所确定的血管造影和操作预测因素可能有助于通过更好的患者选择来改善操作结果。